Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ABEO

Abeona Therapeutics (ABEO)

Abeona Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ABEO
DateTimeSourceHeadlineSymbolCompany
10/10/20234:30PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ABEOAbeona Therapeutics Inc
09/29/20235:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABEOAbeona Therapeutics Inc
09/29/20235:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABEOAbeona Therapeutics Inc
09/29/20235:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABEOAbeona Therapeutics Inc
09/29/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABEOAbeona Therapeutics Inc
09/29/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABEOAbeona Therapeutics Inc
09/29/20237:30AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABEOAbeona Therapeutics Inc
09/26/20237:30AMGlobeNewswire Inc.Abeona Therapeutics Submits Biologics License Application to U.S. FDA Seeking Priority Review and Approval of EB-101 for the Treatment of Patients with Recessive Dystrophic Epidermolysis BullosaNASDAQ:ABEOAbeona Therapeutics Inc
09/22/20234:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABEOAbeona Therapeutics Inc
09/22/20234:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABEOAbeona Therapeutics Inc
09/20/20239:00AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABEOAbeona Therapeutics Inc
09/19/20239:00AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABEOAbeona Therapeutics Inc
09/12/20237:30AMGlobeNewswire Inc.Abeona Therapeutics Appoints Madhav Vasanthavada, Ph.D., M.B.A. as Chief Commercial OfficerNASDAQ:ABEOAbeona Therapeutics Inc
09/07/20237:30AMGlobeNewswire Inc.Abeona Therapeutics Announces Participation in Upcoming Investor ConferencesNASDAQ:ABEOAbeona Therapeutics Inc
08/30/20237:30AMGlobeNewswire Inc.Abeona Therapeutics Announces Positive Pre-BLA Meeting with FDA for EB-101 and Plans for BLA SubmissionNASDAQ:ABEOAbeona Therapeutics Inc
08/08/20238:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABEOAbeona Therapeutics Inc
08/08/20237:30AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABEOAbeona Therapeutics Inc
08/08/20237:30AMGlobeNewswire Inc.Abeona Therapeutics Reports Second Quarter 2023 Financial ResultsNASDAQ:ABEOAbeona Therapeutics Inc
07/28/20237:30AMGlobeNewswire Inc.Abeona Therapeutics Announces Submission of Briefing Package for Pre-Biologics License Application (BLA) Meeting with FDA in August 2023NASDAQ:ABEOAbeona Therapeutics Inc
07/25/20238:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABEOAbeona Therapeutics Inc
07/19/20238:30AMGlobeNewswire Inc.Abeona Therapeutics Joins Rare Disease Company CoalitionNASDAQ:ABEOAbeona Therapeutics Inc
07/10/202310:41AMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ABEOAbeona Therapeutics Inc
07/07/20238:41AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABEOAbeona Therapeutics Inc
07/07/20238:30AMGlobeNewswire Inc.Abeona Therapeutics Announces Closing of $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:ABEOAbeona Therapeutics Inc
07/06/20234:31PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ABEOAbeona Therapeutics Inc
07/03/20238:54AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABEOAbeona Therapeutics Inc
07/03/20238:45AMGlobeNewswire Inc.Abeona Therapeutics Announces $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:ABEOAbeona Therapeutics Inc
07/03/20238:34AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ABEOAbeona Therapeutics Inc
06/16/20234:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ABEOAbeona Therapeutics Inc
06/16/20234:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ABEOAbeona Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ABEO